Eli Lilly has officially ended its collaboration with Nektar Therapeutics on the...
Novartis is eliminating its pipeline the old-fashioned way. The Swiss pharmaceut...
Revolo Biotherapeutics believes that it possesses the data necessary to continue...
Roche’s antibody drug Polivy has been given the green light by the Food and Drug...
GSK has decided to pay $2 billion in cash to acquire Canadian-based medicine dev...
Biotech firm Moderna has released comprehensive data from mid-stage research on ...
Eli Lilly’s mirikizumab, an IL-23 inhibitor, has recently been rejected by the F...
Illumina has entered into a joint agreement with Henry Ford Health to analyze th...
Noah Medical, a Silicon Valley-based robotic lung surgery company, has raised $1...
This week we take a look at Moderna’s less than ideal flu vaccine trial results,...
Candesant Biomedical’s adhesive patch for heavy underarm perspiration has been a...
Moderna has stated that the company’s first-ever seasonal flu vaccine has not me...
NewYork-based healthcare company Crystal Run has been reportedly purchased by Un...
Evernorth, a subsidiary of the healthcare company Cigna, has recently launched a...
After filing for bankruptcy last December, Clovis Oncology found a tentative buy...
Pharmaceutical company AstraZeneca has revealed that a Phase 3 clinical trial of...
